Wisconsin shows faith in Cytogen with more cash
This article was originally published in Clinica
Executive Summary
The largest shareholder of Cytogen, an oncology imaging and proteomics company, the State of Wisconsin Investment Board, is adding a further $8.19 million to the company's equity by buying 1.8 million shares at $4.50 a share. Wisconsin already owns 2.9 million shares in the New Jersey-based biopharmaceutical company.